Thrombotic Risk Screen Test
Introduction
The Thrombotic Risk Screen Test is a critical diagnostic tool designed to evaluate an individual’s risk of developing thrombotic events, such as deep vein thrombosis (DVT) and pulmonary embolism (PE). These conditions can lead to severe complications if not identified and managed promptly. Understanding your thrombotic risk is essential for preventative health care and ensuring timely interventions.
What the Test Measures
This test measures several key components involved in coagulation, including:
- Protein C Functional
- Protein S Antigen, Free
- Antithrombin Activity Functional
- Activated Protein C Resistance (APCR)
Who Should Consider This Test
The Thrombotic Risk Screen Test is recommended for individuals who exhibit symptoms or have risk factors associated with thrombotic disorders, including:
- Family history of thrombosis
- Personal history of blood clots
- Prolonged immobility (e.g., long flights, bed rest)
- Obesity or other metabolic disorders
- Certain genetic conditions affecting blood coagulation
Benefits of Taking the Test
Taking the Thrombotic Risk Screen Test offers several benefits:
- Identifies individuals at risk for thrombotic events.
- Facilitates timely intervention and management strategies.
- Provides peace of mind for patients and their families.
- Helps healthcare providers tailor treatment plans effectively.
Understanding Your Results
Results from the Thrombotic Risk Screen Test will be interpreted by a qualified hematologist. Understanding these results is crucial, as they will indicate your risk level for thrombotic conditions and guide any necessary follow-up actions or treatments.
Test Details and Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Thrombotic Risk Screen Test | 350,000 NGN | 500,000 NGN |
Pre-Test Instructions
To ensure accurate results, please follow these pre-test instructions:
- Overnight fasting is preferred.
- Duly filled Coagulation Requisition Form (Form 15) is mandatory.
- It is recommended that patients discontinue Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling, as these drugs may affect test results. Discontinuation should be with prior consent from the treating Physician.
Sample Collection
The sample type required for this test is 6 mL of whole blood collected in 2 Blue Top (Sodium Citrate) tubes. It is essential to mix the sample thoroughly by inversion and transport it to the lab within 4 hours. If this is not possible, please follow the guidelines for preparing the Platelet Poor Plasma (PPP) as specified.
Book Your Test Today
Don’t leave your health to chance! Book the Thrombotic Risk Screen Test today at DNA Labs Nigeria. For more information or to schedule your appointment, please call or WhatsApp us at +2348077798758.
